Neuraxis (AMEX: NRXS) reported quarterly losses of $(0.18) per share which beat the analyst consensus estimate of $(0.19) by 5.26 percent. This is a 45.45 percent increase over losses of $(0.33) per share from the same period last year. The company reported quarterly sales of $1.607 million which beat the analyst consensus estimate of $1.450 million by 10.83 percent. This is a 79.42 percent increase over sales of $895.655 thousand the same period last year.